Andrew Parshad is a former Quality Assurance Manager from two top natural health products companies in North America. In the last five years Andrew built the quality assurance programs from ground up, for these organizations. During his years there he developed cross functional processes, initiated validation programs for testing products and created the foundation of a total quality management program as some of his achievements. He was also instrumental in obtaining a site license at one of the companies.
Andrew also has 5 years experience in the research field having worked with world renowned leader in creatine metabolism (often referred to as a "creatine guru") Dr. Mark Tarnopolsky. From his research experience at McMaster Andrew was a co-author on several publications and also acknowledged for his technical expertise.
Andrew received his Bachelor of Science (Honours) from McMaster University with a specialization in Biology. He also has a Masters of Business Administration in Strategic Management from Niagara University.
- Muscle Nerve 2001 May 24(5): 682-688. Creatine transporter and mitochondrial creatine kinase protein content in myopathies.
- Mol. Cell Biochem 2003 Feb; 244(1-2):159-66. Acute and Moderate term creatine monohydrate supplementation does not affect creatine transporter mRNA or protein content in either young or elderly humans.
- Can. J. App Physiol. 25(5):396. The effect of Creatine on miCK and creaT protein expression following resistance training.
Arteriosclerosis, Thrombosis and Vascular Biology. 1998 18:816-824. Pretreatment of Rabbits With Either Hirudin, Ancrod, or Warfarin Significantly Reduces the Immediate Uptake of Fibrinogen and Platelets by the Deendothelialized Aorta Wall After Balloon-Catheter Injury In Vivo.
|
